nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ALB—multiple sclerosis	0.27	1	CbGaD
Pitavastatin—ABCG2—Cladribine—multiple sclerosis	0.0856	0.149	CbGbCtD
Pitavastatin—ABCG2—Mitoxantrone—multiple sclerosis	0.0624	0.108	CbGbCtD
Pitavastatin—SLCO1B3—Methotrexate—multiple sclerosis	0.0562	0.0976	CbGbCtD
Pitavastatin—ABCC2—Dexamethasone—multiple sclerosis	0.0358	0.0622	CbGbCtD
Pitavastatin—ALB—Prednisone—multiple sclerosis	0.0357	0.0621	CbGbCtD
Pitavastatin—SLCO1B1—Methotrexate—multiple sclerosis	0.0327	0.0569	CbGbCtD
Pitavastatin—ABCG2—Dexamethasone—multiple sclerosis	0.0324	0.0562	CbGbCtD
Pitavastatin—ABCB1—Methylprednisolone—multiple sclerosis	0.0309	0.0536	CbGbCtD
Pitavastatin—ABCC2—Methotrexate—multiple sclerosis	0.0288	0.05	CbGbCtD
Pitavastatin—ABCG2—Methotrexate—multiple sclerosis	0.026	0.0452	CbGbCtD
Pitavastatin—ABCB1—Mitoxantrone—multiple sclerosis	0.0225	0.0391	CbGbCtD
Pitavastatin—ABCB1—Betamethasone—multiple sclerosis	0.0201	0.0348	CbGbCtD
Pitavastatin—ABCB1—Prednisolone—multiple sclerosis	0.0198	0.0344	CbGbCtD
Pitavastatin—ABCB1—Prednisone—multiple sclerosis	0.0187	0.0325	CbGbCtD
Pitavastatin—ALB—Methotrexate—multiple sclerosis	0.0179	0.0311	CbGbCtD
Pitavastatin—CYP2C8—Dexamethasone—multiple sclerosis	0.0172	0.0299	CbGbCtD
Pitavastatin—CYP2C9—Dexamethasone—multiple sclerosis	0.012	0.0209	CbGbCtD
Pitavastatin—ABCB1—Dexamethasone—multiple sclerosis	0.0117	0.0203	CbGbCtD
Pitavastatin—ABCB1—Methotrexate—multiple sclerosis	0.00938	0.0163	CbGbCtD
Pitavastatin—Cognitive impairment—Betamethasone—multiple sclerosis	0.00299	0.0256	CcSEcCtD
Pitavastatin—Cognitive impairment—Prednisone—multiple sclerosis	0.0026	0.0223	CcSEcCtD
Pitavastatin—Interstitial lung disease—Cladribine—multiple sclerosis	0.00245	0.021	CcSEcCtD
Pitavastatin—Memory loss—Prednisone—multiple sclerosis	0.00231	0.0198	CcSEcCtD
Pitavastatin—Cognitive impairment—Methotrexate—multiple sclerosis	0.00218	0.0187	CcSEcCtD
Pitavastatin—Interstitial lung disease—Azathioprine—multiple sclerosis	0.00199	0.0171	CcSEcCtD
Pitavastatin—Cognitive disorder—Methylprednisolone—multiple sclerosis	0.00198	0.017	CcSEcCtD
Pitavastatin—Influenza—Fingolimod—multiple sclerosis	0.00192	0.0165	CcSEcCtD
Pitavastatin—Cognitive disorder—Betamethasone—multiple sclerosis	0.0018	0.0155	CcSEcCtD
Pitavastatin—Cognitive disorder—Dexamethasone—multiple sclerosis	0.0018	0.0155	CcSEcCtD
Pitavastatin—Interstitial lung disease—Mitoxantrone—multiple sclerosis	0.00161	0.0138	CcSEcCtD
Pitavastatin—Cognitive disorder—Prednisone—multiple sclerosis	0.00157	0.0135	CcSEcCtD
Pitavastatin—Hepatic failure—Cladribine—multiple sclerosis	0.0014	0.012	CcSEcCtD
Pitavastatin—Renal failure acute—Cladribine—multiple sclerosis	0.00136	0.0117	CcSEcCtD
Pitavastatin—Myopathy—Prednisolone—multiple sclerosis	0.00133	0.0114	CcSEcCtD
Pitavastatin—Cognitive disorder—Methotrexate—multiple sclerosis	0.00131	0.0113	CcSEcCtD
Pitavastatin—Back pain—Fingolimod—multiple sclerosis	0.00129	0.0111	CcSEcCtD
Pitavastatin—Pain in extremity—Cladribine—multiple sclerosis	0.00126	0.0108	CcSEcCtD
Pitavastatin—Myopathy—Triamcinolone—multiple sclerosis	0.00123	0.0105	CcSEcCtD
Pitavastatin—Myopathy—Methylprednisolone—multiple sclerosis	0.00122	0.0105	CcSEcCtD
Pitavastatin—Hepatic failure—Azathioprine—multiple sclerosis	0.00114	0.00977	CcSEcCtD
Pitavastatin—Myopathy—Betamethasone—multiple sclerosis	0.00111	0.00954	CcSEcCtD
Pitavastatin—Myopathy—Dexamethasone—multiple sclerosis	0.00111	0.00954	CcSEcCtD
Pitavastatin—Abdominal discomfort—Cladribine—multiple sclerosis	0.00104	0.00894	CcSEcCtD
Pitavastatin—Myopathy—Prednisone—multiple sclerosis	0.000969	0.00831	CcSEcCtD
Pitavastatin—Fatigue—Fingolimod—multiple sclerosis	0.000941	0.00807	CcSEcCtD
Pitavastatin—Renal failure acute—Mitoxantrone—multiple sclerosis	0.000896	0.00768	CcSEcCtD
Pitavastatin—Memory impairment—Prednisone—multiple sclerosis	0.000866	0.00742	CcSEcCtD
Pitavastatin—Abdominal discomfort—Azathioprine—multiple sclerosis	0.000848	0.00727	CcSEcCtD
Pitavastatin—Interstitial lung disease—Methotrexate—multiple sclerosis	0.000802	0.00688	CcSEcCtD
Pitavastatin—Asthenia—Fingolimod—multiple sclerosis	0.000783	0.00671	CcSEcCtD
Pitavastatin—Pruritus—Fingolimod—multiple sclerosis	0.000772	0.00662	CcSEcCtD
Pitavastatin—Diarrhoea—Fingolimod—multiple sclerosis	0.000747	0.0064	CcSEcCtD
Pitavastatin—Back pain—Cladribine—multiple sclerosis	0.000733	0.00629	CcSEcCtD
Pitavastatin—Dizziness—Fingolimod—multiple sclerosis	0.000722	0.00619	CcSEcCtD
Pitavastatin—Ill-defined disorder—Cladribine—multiple sclerosis	0.000703	0.00603	CcSEcCtD
Pitavastatin—Headache—Fingolimod—multiple sclerosis	0.000684	0.00586	CcSEcCtD
Pitavastatin—Malaise—Cladribine—multiple sclerosis	0.000683	0.00586	CcSEcCtD
Pitavastatin—Amnesia—Methylprednisolone—multiple sclerosis	0.000663	0.00568	CcSEcCtD
Pitavastatin—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.000658	0.00565	CcSEcCtD
Pitavastatin—Myalgia—Cladribine—multiple sclerosis	0.000645	0.00553	CcSEcCtD
Pitavastatin—Arthralgia—Cladribine—multiple sclerosis	0.000645	0.00553	CcSEcCtD
Pitavastatin—Discomfort—Cladribine—multiple sclerosis	0.000638	0.00547	CcSEcCtD
Pitavastatin—Confusional state—Cladribine—multiple sclerosis	0.000624	0.00535	CcSEcCtD
Pitavastatin—Jaundice—Mitoxantrone—multiple sclerosis	0.000621	0.00533	CcSEcCtD
Pitavastatin—Hepatitis—Mitoxantrone—multiple sclerosis	0.000572	0.00491	CcSEcCtD
Pitavastatin—Ill-defined disorder—Azathioprine—multiple sclerosis	0.000572	0.0049	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000564	0.00483	CcSEcCtD
Pitavastatin—Insomnia—Cladribine—multiple sclerosis	0.000559	0.0048	CcSEcCtD
Pitavastatin—Malaise—Azathioprine—multiple sclerosis	0.000556	0.00477	CcSEcCtD
Pitavastatin—Influenza—Triamcinolone—multiple sclerosis	0.000539	0.00463	CcSEcCtD
Pitavastatin—Fatigue—Cladribine—multiple sclerosis	0.000533	0.00457	CcSEcCtD
Pitavastatin—Constipation—Cladribine—multiple sclerosis	0.000529	0.00454	CcSEcCtD
Pitavastatin—Amnesia—Prednisone—multiple sclerosis	0.000525	0.0045	CcSEcCtD
Pitavastatin—Myalgia—Azathioprine—multiple sclerosis	0.000525	0.0045	CcSEcCtD
Pitavastatin—Arthralgia—Azathioprine—multiple sclerosis	0.000525	0.0045	CcSEcCtD
Pitavastatin—Discomfort—Azathioprine—multiple sclerosis	0.000518	0.00445	CcSEcCtD
Pitavastatin—Feeling abnormal—Cladribine—multiple sclerosis	0.00051	0.00437	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000506	0.00434	CcSEcCtD
Pitavastatin—Urticaria—Cladribine—multiple sclerosis	0.000491	0.00421	CcSEcCtD
Pitavastatin—Abdominal pain—Cladribine—multiple sclerosis	0.000489	0.00419	CcSEcCtD
Pitavastatin—Back pain—Mitoxantrone—multiple sclerosis	0.000482	0.00413	CcSEcCtD
Pitavastatin—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000462	0.00396	CcSEcCtD
Pitavastatin—Hepatic failure—Methotrexate—multiple sclerosis	0.000459	0.00393	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000458	0.00393	CcSEcCtD
Pitavastatin—Hypersensitivity—Cladribine—multiple sclerosis	0.000456	0.00391	CcSEcCtD
Pitavastatin—Malaise—Mitoxantrone—multiple sclerosis	0.000449	0.00385	CcSEcCtD
Pitavastatin—Renal failure acute—Methotrexate—multiple sclerosis	0.000446	0.00383	CcSEcCtD
Pitavastatin—Asthenia—Cladribine—multiple sclerosis	0.000444	0.00381	CcSEcCtD
Pitavastatin—Pruritus—Cladribine—multiple sclerosis	0.000438	0.00375	CcSEcCtD
Pitavastatin—Myalgia—Mitoxantrone—multiple sclerosis	0.000424	0.00364	CcSEcCtD
Pitavastatin—Arthralgia—Mitoxantrone—multiple sclerosis	0.000424	0.00364	CcSEcCtD
Pitavastatin—Diarrhoea—Cladribine—multiple sclerosis	0.000423	0.00363	CcSEcCtD
Pitavastatin—Discomfort—Mitoxantrone—multiple sclerosis	0.000419	0.00359	CcSEcCtD
Pitavastatin—Feeling abnormal—Azathioprine—multiple sclerosis	0.000414	0.00355	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000411	0.00353	CcSEcCtD
Pitavastatin—Confusional state—Mitoxantrone—multiple sclerosis	0.00041	0.00352	CcSEcCtD
Pitavastatin—Dizziness—Cladribine—multiple sclerosis	0.000409	0.00351	CcSEcCtD
Pitavastatin—Abdominal pain—Azathioprine—multiple sclerosis	0.000398	0.00341	CcSEcCtD
Pitavastatin—Erectile dysfunction—Prednisone—multiple sclerosis	0.000393	0.00337	CcSEcCtD
Pitavastatin—Rash—Cladribine—multiple sclerosis	0.00039	0.00334	CcSEcCtD
Pitavastatin—Dermatitis—Cladribine—multiple sclerosis	0.00039	0.00334	CcSEcCtD
Pitavastatin—Headache—Cladribine—multiple sclerosis	0.000388	0.00332	CcSEcCtD
Pitavastatin—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000379	0.00325	CcSEcCtD
Pitavastatin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000371	0.00318	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00037	0.00318	CcSEcCtD
Pitavastatin—Malaise—Prednisolone—multiple sclerosis	0.000369	0.00316	CcSEcCtD
Pitavastatin—Nausea—Cladribine—multiple sclerosis	0.000367	0.00315	CcSEcCtD
Pitavastatin—Back pain—Triamcinolone—multiple sclerosis	0.000364	0.00312	CcSEcCtD
Pitavastatin—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000358	0.00307	CcSEcCtD
Pitavastatin—Fatigue—Mitoxantrone—multiple sclerosis	0.000351	0.00301	CcSEcCtD
Pitavastatin—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000349	0.00299	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000348	0.00298	CcSEcCtD
Pitavastatin—Constipation—Mitoxantrone—multiple sclerosis	0.000348	0.00298	CcSEcCtD
Pitavastatin—Diarrhoea—Azathioprine—multiple sclerosis	0.000344	0.00295	CcSEcCtD
Pitavastatin—Discomfort—Prednisolone—multiple sclerosis	0.000344	0.00295	CcSEcCtD
Pitavastatin—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000342	0.00293	CcSEcCtD
Pitavastatin—Malaise—Triamcinolone—multiple sclerosis	0.000339	0.00291	CcSEcCtD
Pitavastatin—Malaise—Methylprednisolone—multiple sclerosis	0.000338	0.0029	CcSEcCtD
Pitavastatin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000335	0.00287	CcSEcCtD
Pitavastatin—Dizziness—Azathioprine—multiple sclerosis	0.000333	0.00285	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000332	0.00285	CcSEcCtD
Pitavastatin—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000328	0.00281	CcSEcCtD
Pitavastatin—Urticaria—Mitoxantrone—multiple sclerosis	0.000323	0.00277	CcSEcCtD
Pitavastatin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000321	0.00276	CcSEcCtD
Pitavastatin—Myalgia—Triamcinolone—multiple sclerosis	0.00032	0.00274	CcSEcCtD
Pitavastatin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000319	0.00274	CcSEcCtD
Pitavastatin—Myalgia—Methylprednisolone—multiple sclerosis	0.000319	0.00274	CcSEcCtD
Pitavastatin—Rash—Azathioprine—multiple sclerosis	0.000317	0.00272	CcSEcCtD
Pitavastatin—Dermatitis—Azathioprine—multiple sclerosis	0.000317	0.00272	CcSEcCtD
Pitavastatin—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000316	0.00271	CcSEcCtD
Pitavastatin—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000316	0.00271	CcSEcCtD
Pitavastatin—Discomfort—Triamcinolone—multiple sclerosis	0.000316	0.00271	CcSEcCtD
Pitavastatin—Discomfort—Methylprednisolone—multiple sclerosis	0.000315	0.00271	CcSEcCtD
Pitavastatin—Headache—Azathioprine—multiple sclerosis	0.000315	0.0027	CcSEcCtD
Pitavastatin—Confusional state—Methylprednisolone—multiple sclerosis	0.000309	0.00265	CcSEcCtD
Pitavastatin—Malaise—Betamethasone—multiple sclerosis	0.000308	0.00264	CcSEcCtD
Pitavastatin—Malaise—Dexamethasone—multiple sclerosis	0.000308	0.00264	CcSEcCtD
Pitavastatin—Insomnia—Prednisolone—multiple sclerosis	0.000302	0.00259	CcSEcCtD
Pitavastatin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.0003	0.00257	CcSEcCtD
Pitavastatin—Nausea—Azathioprine—multiple sclerosis	0.000299	0.00256	CcSEcCtD
Pitavastatin—Asthenia—Mitoxantrone—multiple sclerosis	0.000292	0.0025	CcSEcCtD
Pitavastatin—Myalgia—Betamethasone—multiple sclerosis	0.00029	0.00249	CcSEcCtD
Pitavastatin—Myalgia—Dexamethasone—multiple sclerosis	0.00029	0.00249	CcSEcCtD
Pitavastatin—Discomfort—Betamethasone—multiple sclerosis	0.000287	0.00246	CcSEcCtD
Pitavastatin—Discomfort—Dexamethasone—multiple sclerosis	0.000287	0.00246	CcSEcCtD
Pitavastatin—Hepatitis—Methotrexate—multiple sclerosis	0.000285	0.00245	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000279	0.0024	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000279	0.00239	CcSEcCtD
Pitavastatin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000278	0.00239	CcSEcCtD
Pitavastatin—Insomnia—Triamcinolone—multiple sclerosis	0.000277	0.00238	CcSEcCtD
Pitavastatin—Insomnia—Methylprednisolone—multiple sclerosis	0.000277	0.00237	CcSEcCtD
Pitavastatin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000276	0.00236	CcSEcCtD
Pitavastatin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000275	0.00236	CcSEcCtD
Pitavastatin—Dyspepsia—Triamcinolone—multiple sclerosis	0.00027	0.00232	CcSEcCtD
Pitavastatin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000269	0.00231	CcSEcCtD
Pitavastatin—Malaise—Prednisone—multiple sclerosis	0.000268	0.0023	CcSEcCtD
Pitavastatin—Urticaria—Prednisolone—multiple sclerosis	0.000265	0.00227	CcSEcCtD
Pitavastatin—Fatigue—Triamcinolone—multiple sclerosis	0.000264	0.00227	CcSEcCtD
Pitavastatin—Fatigue—Methylprednisolone—multiple sclerosis	0.000264	0.00226	CcSEcCtD
Pitavastatin—Rash—Mitoxantrone—multiple sclerosis	0.000256	0.0022	CcSEcCtD
Pitavastatin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000256	0.0022	CcSEcCtD
Pitavastatin—Headache—Mitoxantrone—multiple sclerosis	0.000255	0.00218	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000254	0.00217	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000254	0.00217	CcSEcCtD
Pitavastatin—Arthralgia—Prednisone—multiple sclerosis	0.000253	0.00217	CcSEcCtD
Pitavastatin—Myalgia—Prednisone—multiple sclerosis	0.000253	0.00217	CcSEcCtD
Pitavastatin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000253	0.00217	CcSEcCtD
Pitavastatin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000252	0.00216	CcSEcCtD
Pitavastatin—Insomnia—Dexamethasone—multiple sclerosis	0.000252	0.00216	CcSEcCtD
Pitavastatin—Insomnia—Betamethasone—multiple sclerosis	0.000252	0.00216	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00025	0.00215	CcSEcCtD
Pitavastatin—Discomfort—Prednisone—multiple sclerosis	0.00025	0.00214	CcSEcCtD
Pitavastatin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000246	0.00211	CcSEcCtD
Pitavastatin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000245	0.0021	CcSEcCtD
Pitavastatin—Dyspepsia—Betamethasone—multiple sclerosis	0.000245	0.0021	CcSEcCtD
Pitavastatin—Urticaria—Triamcinolone—multiple sclerosis	0.000244	0.00209	CcSEcCtD
Pitavastatin—Urticaria—Methylprednisolone—multiple sclerosis	0.000243	0.00209	CcSEcCtD
Pitavastatin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000242	0.00207	CcSEcCtD
Pitavastatin—Nausea—Mitoxantrone—multiple sclerosis	0.000242	0.00207	CcSEcCtD
Pitavastatin—Back pain—Methotrexate—multiple sclerosis	0.00024	0.00206	CcSEcCtD
Pitavastatin—Fatigue—Betamethasone—multiple sclerosis	0.00024	0.00206	CcSEcCtD
Pitavastatin—Fatigue—Dexamethasone—multiple sclerosis	0.00024	0.00206	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00023	0.00197	CcSEcCtD
Pitavastatin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000229	0.00197	CcSEcCtD
Pitavastatin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000229	0.00197	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000228	0.00195	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000228	0.00195	CcSEcCtD
Pitavastatin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000226	0.00194	CcSEcCtD
Pitavastatin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000225	0.00193	CcSEcCtD
Pitavastatin—Malaise—Methotrexate—multiple sclerosis	0.000224	0.00192	CcSEcCtD
Pitavastatin—Urticaria—Betamethasone—multiple sclerosis	0.000221	0.0019	CcSEcCtD
Pitavastatin—Urticaria—Dexamethasone—multiple sclerosis	0.000221	0.0019	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000221	0.00189	CcSEcCtD
Pitavastatin—Dizziness—Prednisolone—multiple sclerosis	0.000221	0.00189	CcSEcCtD
Pitavastatin—Asthenia—Triamcinolone—multiple sclerosis	0.00022	0.00189	CcSEcCtD
Pitavastatin—Abdominal pain—Betamethasone—multiple sclerosis	0.00022	0.00189	CcSEcCtD
Pitavastatin—Abdominal pain—Dexamethasone—multiple sclerosis	0.00022	0.00189	CcSEcCtD
Pitavastatin—Asthenia—Methylprednisolone—multiple sclerosis	0.00022	0.00188	CcSEcCtD
Pitavastatin—Insomnia—Prednisone—multiple sclerosis	0.000219	0.00188	CcSEcCtD
Pitavastatin—Pruritus—Triamcinolone—multiple sclerosis	0.000217	0.00186	CcSEcCtD
Pitavastatin—Pruritus—Methylprednisolone—multiple sclerosis	0.000217	0.00186	CcSEcCtD
Pitavastatin—Dyspepsia—Prednisone—multiple sclerosis	0.000213	0.00183	CcSEcCtD
Pitavastatin—Arthralgia—Methotrexate—multiple sclerosis	0.000211	0.00181	CcSEcCtD
Pitavastatin—Myalgia—Methotrexate—multiple sclerosis	0.000211	0.00181	CcSEcCtD
Pitavastatin—Rash—Prednisolone—multiple sclerosis	0.00021	0.0018	CcSEcCtD
Pitavastatin—Dermatitis—Prednisolone—multiple sclerosis	0.00021	0.0018	CcSEcCtD
Pitavastatin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000209	0.0018	CcSEcCtD
Pitavastatin—Fatigue—Prednisone—multiple sclerosis	0.000209	0.00179	CcSEcCtD
Pitavastatin—Headache—Prednisolone—multiple sclerosis	0.000209	0.00179	CcSEcCtD
Pitavastatin—Discomfort—Methotrexate—multiple sclerosis	0.000209	0.00179	CcSEcCtD
Pitavastatin—Constipation—Prednisone—multiple sclerosis	0.000207	0.00178	CcSEcCtD
Pitavastatin—Confusional state—Methotrexate—multiple sclerosis	0.000204	0.00175	CcSEcCtD
Pitavastatin—Dizziness—Triamcinolone—multiple sclerosis	0.000203	0.00174	CcSEcCtD
Pitavastatin—Dizziness—Methylprednisolone—multiple sclerosis	0.000202	0.00174	CcSEcCtD
Pitavastatin—Feeling abnormal—Prednisone—multiple sclerosis	0.0002	0.00171	CcSEcCtD
Pitavastatin—Asthenia—Dexamethasone—multiple sclerosis	0.0002	0.00171	CcSEcCtD
Pitavastatin—Asthenia—Betamethasone—multiple sclerosis	0.0002	0.00171	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000198	0.0017	CcSEcCtD
Pitavastatin—Nausea—Prednisolone—multiple sclerosis	0.000198	0.0017	CcSEcCtD
Pitavastatin—Pruritus—Dexamethasone—multiple sclerosis	0.000197	0.00169	CcSEcCtD
Pitavastatin—Pruritus—Betamethasone—multiple sclerosis	0.000197	0.00169	CcSEcCtD
Pitavastatin—Rash—Triamcinolone—multiple sclerosis	0.000193	0.00166	CcSEcCtD
Pitavastatin—Dermatitis—Triamcinolone—multiple sclerosis	0.000193	0.00166	CcSEcCtD
Pitavastatin—Rash—Methylprednisolone—multiple sclerosis	0.000193	0.00165	CcSEcCtD
Pitavastatin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000193	0.00165	CcSEcCtD
Pitavastatin—Urticaria—Prednisone—multiple sclerosis	0.000193	0.00165	CcSEcCtD
Pitavastatin—Headache—Triamcinolone—multiple sclerosis	0.000192	0.00165	CcSEcCtD
Pitavastatin—Headache—Methylprednisolone—multiple sclerosis	0.000192	0.00164	CcSEcCtD
Pitavastatin—Abdominal pain—Prednisone—multiple sclerosis	0.000192	0.00164	CcSEcCtD
Pitavastatin—Diarrhoea—Betamethasone—multiple sclerosis	0.00019	0.00163	CcSEcCtD
Pitavastatin—Diarrhoea—Dexamethasone—multiple sclerosis	0.00019	0.00163	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000185	0.00158	CcSEcCtD
Pitavastatin—Dizziness—Betamethasone—multiple sclerosis	0.000184	0.00158	CcSEcCtD
Pitavastatin—Dizziness—Dexamethasone—multiple sclerosis	0.000184	0.00158	CcSEcCtD
Pitavastatin—Insomnia—Methotrexate—multiple sclerosis	0.000183	0.00157	CcSEcCtD
Pitavastatin—Nausea—Triamcinolone—multiple sclerosis	0.000182	0.00156	CcSEcCtD
Pitavastatin—Nausea—Methylprednisolone—multiple sclerosis	0.000182	0.00156	CcSEcCtD
Pitavastatin—Hypersensitivity—Prednisone—multiple sclerosis	0.000179	0.00153	CcSEcCtD
Pitavastatin—Dyspepsia—Methotrexate—multiple sclerosis	0.000178	0.00153	CcSEcCtD
Pitavastatin—Rash—Dexamethasone—multiple sclerosis	0.000175	0.0015	CcSEcCtD
Pitavastatin—Rash—Betamethasone—multiple sclerosis	0.000175	0.0015	CcSEcCtD
Pitavastatin—Dermatitis—Betamethasone—multiple sclerosis	0.000175	0.0015	CcSEcCtD
Pitavastatin—Dermatitis—Dexamethasone—multiple sclerosis	0.000175	0.0015	CcSEcCtD
Pitavastatin—Fatigue—Methotrexate—multiple sclerosis	0.000175	0.0015	CcSEcCtD
Pitavastatin—Headache—Betamethasone—multiple sclerosis	0.000174	0.0015	CcSEcCtD
Pitavastatin—Headache—Dexamethasone—multiple sclerosis	0.000174	0.0015	CcSEcCtD
Pitavastatin—Asthenia—Prednisone—multiple sclerosis	0.000174	0.00149	CcSEcCtD
Pitavastatin—Pruritus—Prednisone—multiple sclerosis	0.000171	0.00147	CcSEcCtD
Pitavastatin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000167	0.00143	CcSEcCtD
Pitavastatin—Diarrhoea—Prednisone—multiple sclerosis	0.000166	0.00142	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000166	0.00142	CcSEcCtD
Pitavastatin—Nausea—Dexamethasone—multiple sclerosis	0.000165	0.00142	CcSEcCtD
Pitavastatin—Nausea—Betamethasone—multiple sclerosis	0.000165	0.00142	CcSEcCtD
Pitavastatin—Urticaria—Methotrexate—multiple sclerosis	0.000161	0.00138	CcSEcCtD
Pitavastatin—Dizziness—Prednisone—multiple sclerosis	0.00016	0.00137	CcSEcCtD
Pitavastatin—Abdominal pain—Methotrexate—multiple sclerosis	0.00016	0.00137	CcSEcCtD
Pitavastatin—Rash—Prednisone—multiple sclerosis	0.000153	0.00131	CcSEcCtD
Pitavastatin—Dermatitis—Prednisone—multiple sclerosis	0.000153	0.00131	CcSEcCtD
Pitavastatin—Headache—Prednisone—multiple sclerosis	0.000152	0.0013	CcSEcCtD
Pitavastatin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000149	0.00128	CcSEcCtD
Pitavastatin—Asthenia—Methotrexate—multiple sclerosis	0.000145	0.00125	CcSEcCtD
Pitavastatin—Nausea—Prednisone—multiple sclerosis	0.000144	0.00123	CcSEcCtD
Pitavastatin—Pruritus—Methotrexate—multiple sclerosis	0.000143	0.00123	CcSEcCtD
Pitavastatin—Diarrhoea—Methotrexate—multiple sclerosis	0.000139	0.00119	CcSEcCtD
Pitavastatin—Dizziness—Methotrexate—multiple sclerosis	0.000134	0.00115	CcSEcCtD
Pitavastatin—Rash—Methotrexate—multiple sclerosis	0.000128	0.0011	CcSEcCtD
Pitavastatin—Dermatitis—Methotrexate—multiple sclerosis	0.000128	0.00109	CcSEcCtD
Pitavastatin—Headache—Methotrexate—multiple sclerosis	0.000127	0.00109	CcSEcCtD
Pitavastatin—Nausea—Methotrexate—multiple sclerosis	0.00012	0.00103	CcSEcCtD
Pitavastatin—Rosuvastatin—ALB—multiple sclerosis	0.000117	1	CrCbGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.13e-05	0.00243	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.94e-05	0.00238	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CYP27B1—multiple sclerosis	8.87e-05	0.00236	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CYP24A1—multiple sclerosis	8.87e-05	0.00236	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	8.86e-05	0.00236	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	8.79e-05	0.00234	CbGpPWpGaD
Pitavastatin—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	8.78e-05	0.00234	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.67e-05	0.00231	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.65e-05	0.0023	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	8.64e-05	0.0023	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.57e-05	0.00228	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CD40—multiple sclerosis	8.46e-05	0.00225	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.38e-05	0.00223	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.38e-05	0.00223	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—SRM—multiple sclerosis	8.37e-05	0.00223	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	8.33e-05	0.00222	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	8.32e-05	0.00221	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL4—multiple sclerosis	8.31e-05	0.00221	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GPC5—multiple sclerosis	8.12e-05	0.00216	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	8.11e-05	0.00216	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.94e-05	0.00211	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—SRM—multiple sclerosis	7.89e-05	0.0021	CbGpPWpGaD
Pitavastatin—UGT1A3—Biological oxidations—POMC—multiple sclerosis	7.76e-05	0.00206	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.64e-05	0.00204	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	7.62e-05	0.00203	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	7.34e-05	0.00195	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	7.31e-05	0.00194	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	7.26e-05	0.00193	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CYP27B1—multiple sclerosis	7.23e-05	0.00193	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CYP24A1—multiple sclerosis	7.23e-05	0.00193	CbGpPWpGaD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	7.18e-05	0.00191	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—SRM—multiple sclerosis	7.12e-05	0.00189	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.07e-05	0.00188	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SELPLG—multiple sclerosis	6.94e-05	0.00185	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MERTK—multiple sclerosis	6.94e-05	0.00185	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—CD58—multiple sclerosis	6.94e-05	0.00185	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.92e-05	0.00184	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	6.86e-05	0.00183	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.76e-05	0.0018	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—RRM1—multiple sclerosis	6.72e-05	0.00179	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GPC5—multiple sclerosis	6.62e-05	0.00176	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CD86—multiple sclerosis	6.61e-05	0.00176	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—ICAM1—multiple sclerosis	6.6e-05	0.00176	CbGpPWpGaD
Pitavastatin—UGT2B7—Biological oxidations—POMC—multiple sclerosis	6.59e-05	0.00176	CbGpPWpGaD
Pitavastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.55e-05	0.00174	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.5e-05	0.00173	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	6.48e-05	0.00173	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL10—multiple sclerosis	6.48e-05	0.00173	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL4—multiple sclerosis	6.3e-05	0.00168	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	6.17e-05	0.00164	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	6.16e-05	0.00164	CbGpPWpGaD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.13e-05	0.00163	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	6.1e-05	0.00162	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.02e-05	0.0016	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	5.97e-05	0.00159	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—CCL2—multiple sclerosis	5.91e-05	0.00157	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP27B1—multiple sclerosis	5.9e-05	0.00157	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP24A1—multiple sclerosis	5.9e-05	0.00157	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—FAS—multiple sclerosis	5.81e-05	0.00155	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.78e-05	0.00154	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.71e-05	0.00152	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP27B1—multiple sclerosis	5.56e-05	0.00148	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP24A1—multiple sclerosis	5.56e-05	0.00148	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	5.51e-05	0.00147	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—RRM1—multiple sclerosis	5.48e-05	0.00146	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.47e-05	0.00146	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.43e-05	0.00145	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GPC5—multiple sclerosis	5.39e-05	0.00144	CbGpPWpGaD
Pitavastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.33e-05	0.00142	CbGpPWpGaD
Pitavastatin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.31e-05	0.00141	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SRM—multiple sclerosis	5.3e-05	0.00141	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	5.24e-05	0.0014	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.22e-05	0.00139	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.22e-05	0.00139	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.14e-05	0.00137	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.11e-05	0.00136	CbGpPWpGaD
Pitavastatin—UGT1A3—NRF2 pathway—TGFB1—multiple sclerosis	5.1e-05	0.00136	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GPC5—multiple sclerosis	5.08e-05	0.00135	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IFNG—multiple sclerosis	5.02e-05	0.00134	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP27B1—multiple sclerosis	5.01e-05	0.00133	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP24A1—multiple sclerosis	5.01e-05	0.00133	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SRM—multiple sclerosis	4.91e-05	0.00131	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.9e-05	0.0013	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.83e-05	0.00129	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.82e-05	0.00128	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.82e-05	0.00128	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.82e-05	0.00128	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.79e-05	0.00127	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.79e-05	0.00127	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.79e-05	0.00127	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.76e-05	0.00127	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	4.69e-05	0.00125	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GPC5—multiple sclerosis	4.59e-05	0.00122	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.54e-05	0.00121	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.48e-05	0.00119	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL1B—multiple sclerosis	4.48e-05	0.00119	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—RRM1—multiple sclerosis	4.47e-05	0.00119	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL2—multiple sclerosis	4.46e-05	0.00119	CbGpPWpGaD
Pitavastatin—UGT2B7—NRF2 pathway—TGFB1—multiple sclerosis	4.34e-05	0.00115	CbGpPWpGaD
Pitavastatin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.32e-05	0.00115	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.29e-05	0.00114	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PLEK—multiple sclerosis	4.29e-05	0.00114	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.25e-05	0.00113	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—RRM1—multiple sclerosis	4.21e-05	0.00112	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.2e-05	0.00112	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.17e-05	0.00111	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.09e-05	0.00109	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	4e-05	0.00106	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.99e-05	0.00106	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.92e-05	0.00104	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.92e-05	0.00104	CbGpPWpGaD
Pitavastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.88e-05	0.00103	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—BCHE—multiple sclerosis	3.86e-05	0.00103	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.81e-05	0.00101	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—RRM1—multiple sclerosis	3.8e-05	0.00101	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	3.73e-05	0.000994	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	3.73e-05	0.000994	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.71e-05	0.000988	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.65e-05	0.000973	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.65e-05	0.000971	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	3.56e-05	0.000947	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP27B1—multiple sclerosis	3.46e-05	0.00092	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP24A1—multiple sclerosis	3.46e-05	0.00092	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	3.44e-05	0.000915	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GPC5—multiple sclerosis	3.41e-05	0.000909	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.4e-05	0.000905	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.39e-05	0.000902	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.35e-05	0.000892	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.33e-05	0.000887	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.27e-05	0.00087	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.25e-05	0.000866	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TNF—multiple sclerosis	3.25e-05	0.000865	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	3.22e-05	0.000858	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.22e-05	0.000856	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GPC5—multiple sclerosis	3.16e-05	0.000842	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—BCHE—multiple sclerosis	3.15e-05	0.000838	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.12e-05	0.000829	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SRM—multiple sclerosis	3.04e-05	0.000811	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SRM—multiple sclerosis	3.03e-05	0.000806	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SELE—multiple sclerosis	3.02e-05	0.000804	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—TGFB1—multiple sclerosis	2.98e-05	0.000795	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.93e-05	0.000781	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.9e-05	0.000771	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.87e-05	0.000763	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.84e-05	0.000757	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—RRM1—multiple sclerosis	2.83e-05	0.000753	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.82e-05	0.000751	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.81e-05	0.000747	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SRM—multiple sclerosis	2.65e-05	0.000706	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.64e-05	0.000703	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL6—multiple sclerosis	2.62e-05	0.000698	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—RRM1—multiple sclerosis	2.62e-05	0.000697	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.59e-05	0.000691	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	2.58e-05	0.000687	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.57e-05	0.000684	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—BCHE—multiple sclerosis	2.57e-05	0.000683	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.56e-05	0.000681	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SRM—multiple sclerosis	2.48e-05	0.00066	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.47e-05	0.000657	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.43e-05	0.000648	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—BCHE—multiple sclerosis	2.42e-05	0.000644	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—APOE—multiple sclerosis	2.32e-05	0.000618	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.3e-05	0.000611	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.27e-05	0.000605	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.2e-05	0.000584	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—ITGA4—multiple sclerosis	2.18e-05	0.000582	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—BCHE—multiple sclerosis	2.18e-05	0.000581	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IFNB1—multiple sclerosis	2.17e-05	0.000577	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.15e-05	0.000571	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.15e-05	0.000571	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP24A1—multiple sclerosis	2.13e-05	0.000568	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP27B1—multiple sclerosis	2.13e-05	0.000568	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.1e-05	0.000558	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.08e-05	0.000555	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	2.08e-05	0.000555	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—POMC—multiple sclerosis	2e-05	0.000531	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.96e-05	0.000522	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GPC5—multiple sclerosis	1.95e-05	0.000519	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—APOE—multiple sclerosis	1.89e-05	0.000504	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.89e-05	0.000502	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.87e-05	0.000498	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.87e-05	0.000498	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ALB—multiple sclerosis	1.82e-05	0.000484	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.75e-05	0.000465	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.75e-05	0.000465	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.74e-05	0.000463	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.72e-05	0.000458	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GPC5—multiple sclerosis	1.71e-05	0.000455	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.71e-05	0.000454	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.7e-05	0.000452	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.63e-05	0.000435	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—POMC—multiple sclerosis	1.63e-05	0.000433	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.63e-05	0.000433	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.63e-05	0.000433	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—RRM1—multiple sclerosis	1.62e-05	0.00043	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.6e-05	0.000425	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—APOE—multiple sclerosis	1.54e-05	0.000411	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.51e-05	0.000403	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—BCHE—multiple sclerosis	1.5e-05	0.000401	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2RA—multiple sclerosis	1.49e-05	0.000397	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ALB—multiple sclerosis	1.48e-05	0.000395	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—APOE—multiple sclerosis	1.46e-05	0.000387	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—RRM1—multiple sclerosis	1.42e-05	0.000377	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—POMC—multiple sclerosis	1.33e-05	0.000353	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.32e-05	0.000352	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.32e-05	0.000352	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—APOE—multiple sclerosis	1.31e-05	0.000349	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.31e-05	0.000348	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.3e-05	0.000347	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.3e-05	0.000346	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.28e-05	0.00034	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.26e-05	0.000336	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.25e-05	0.000334	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—POMC—multiple sclerosis	1.25e-05	0.000333	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.22e-05	0.000324	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ALB—multiple sclerosis	1.21e-05	0.000322	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALB—multiple sclerosis	1.14e-05	0.000303	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—POMC—multiple sclerosis	1.13e-05	0.0003	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.08e-05	0.000288	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.08e-05	0.000287	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—multiple sclerosis	1.03e-05	0.000274	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.03e-05	0.000273	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.88e-06	0.000263	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APOE—multiple sclerosis	9.78e-06	0.00026	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—BCHE—multiple sclerosis	9.34e-06	0.000249	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—BCHE—multiple sclerosis	9.28e-06	0.000247	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APOE—multiple sclerosis	9.05e-06	0.000241	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.82e-06	0.000235	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2—multiple sclerosis	8.75e-06	0.000233	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—POMC—multiple sclerosis	8.4e-06	0.000224	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.18e-06	0.000218	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—BCHE—multiple sclerosis	8.14e-06	0.000217	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.04e-06	0.000214	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—POMC—multiple sclerosis	7.78e-06	0.000207	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—multiple sclerosis	7.66e-06	0.000204	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.6e-06	0.000202	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—multiple sclerosis	7.09e-06	0.000189	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB1—multiple sclerosis	6.82e-06	0.000182	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK1—multiple sclerosis	6.69e-06	0.000178	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOE—multiple sclerosis	5.62e-06	0.00015	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOE—multiple sclerosis	5.59e-06	0.000149	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOE—multiple sclerosis	4.89e-06	0.00013	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—POMC—multiple sclerosis	4.83e-06	0.000128	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—POMC—multiple sclerosis	4.8e-06	0.000128	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOE—multiple sclerosis	4.57e-06	0.000122	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—multiple sclerosis	4.4e-06	0.000117	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—POMC—multiple sclerosis	4.2e-06	0.000112	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—POMC—multiple sclerosis	3.93e-06	0.000105	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—multiple sclerosis	3.83e-06	0.000102	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—multiple sclerosis	3.58e-06	9.53e-05	CbGpPWpGaD
